Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Näytä muut versiot (1)

BACKGROUND: Severe malaria is a major cause of childhood death and often the main reason for paediatric hospital admission in sub-Saharan Africa. Quinine is still the established treatment of choice, although evidence from Asia suggests that artesunate is associated with a lower mortality. We compar...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Dondorp, A, Fanello, C, Hendriksen, I, Gomes, E, Seni, A, Chhaganlal, K, Bojang, K, Olaosebikan, R, Anunobi, N, Maitland, K, Kivaya, E, Agbenyega, T, Nguah, S, Evans, J, Gesase, S, Kahabuka, C, Mtove, G, Nadjm, B, Deen, J, Mwanga-Amumpaire, J, Nansumba, M, Karema, C, Umulisa, N, Uwimana, A, Mokuolu, O
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 2010

Samankaltaisia teoksia